Year in Review 2019: We're Ready
Four Questions with Gilead’s Virology Clinical Research Team: Continuing to Pursue Transformational ...
An Open Letter from Daniel O’Day, Chairman & CEO, Gilead Sciences
Expanding Our Cell Therapy Manufacturing Network to Meet the Needs of Cancer Patients in Europe
Taking Care of Those Who Are Left Out and Left Behind
Profiles in Creating Possible: Jan Pineda is on the Front Lines of Genetically Engineering T Cells t...
Students Find Ways to Learn and Connect During Gilead and Kite Summer Internship Program
Our Partners: George Kalamitsis Helps Hard-to-Reach People at High Risk for Hepatitis C
Gilead and the Morehouse School of Medicine Partner to Study Racial Health Inequities Associated wit...
Four Questions with Shira Kogan: How The Trevor Project is Supporting LGBTQ+ Youth Through the Uncer...
Giving Together to Support California Wildfire Relief Efforts
Tokyo To Open Pride House Highlighting LGBT+ Rights Before Olympics
